Srini Tenjarla insider trades
Open-market stock purchases and sales by Srini Tenjarla, SVP, CMC & Formulation at Serina Therapeutics, Inc, from SEC Form 4 filings since Jul 15, 2024.
Companies traded
- SER Serina Therapeutics, Inc: other filings, last May 21, 2026